Novotech Featured Reports

51. Going Global: How Working With A CRO Can Benefit Clinical Trials 9/12/2023

    Contract research organizations can be invaluable partners in clinical trials. Dive into the full spectrum of benefits you'll experience by partnering with a globally established and well-resourced CRO.

52. Advantages Of Including Europe And APAC Regions For Clinical Research 9/12/2023

    Discover the advantages of incorporating Europe and APAC regions in clinical trial endeavors, such as accelerated recruitment, streamlined regulatory procedures, access to diverse patient populations, and ultimately, significant cost reductions.

53. Antibody Drug Conjugates And The Global Research Landscape 9/12/2023

    Learn about ADCs advancements in cancer treatment and how the therapy could potentially revolutionize the field by reducing the often severe side effects associated with traditional chemotherapy.

54. Location Considerations For Successful Clinical Trials 9/12/2023

    Consider the advantages associated with conducting early- to late-phase clinical trials in China and the broader APAC region, as well as potential challenges that could impact the trial process and patient outcomes

55. Navigating The Evolving Pathways To FDA Approval 9/12/2023

    Gain insight into how teams can create clinical pathways and develop trial designs made for success.

56. An In-Depth Analysis Of CRO Operations And Impact On Drug Development 9/12/2023

    Get a full overview of the role CROs play in clinical trials and their impact on site selection, site monitoring, patient recruitment, managing data, and more.

57. Advancing Treatment Of Gallbladder Cancer 9/12/2023

    Get an overview of the exciting advancements in gallbladder cancer (GBC) treatment, emphasizing pioneering medications, ongoing clinical trials, and their potential to revolutionize patient outcomes.

58. Nasopharyngeal Carcinoma: Facts, Stats, And Research Updates 9/12/2023

    Explore exciting advancements in the treatment of nasopharyngeal carcinoma (NPC), specifically pharmaceuticals, ongoing clinical trials, and their potential to significantly improve patient prognosis and outcomes.

59. Crohn's Disease – Global Clinical Trial Landscape - Focus On Asia Pacific 9/12/2023

    Dive into the global clinical trial landscape of Crohn's disease (CD), its trends in the Asia Pacific, and what the industry is doing to look for a cure.

60. Non-Hodgkin Lymphoma – Global Clinical Trial Landscape - Focus On Asia Pacific 9/12/2023

    Gain a better understanding of the global clinical trial landscape of Non-Hodgkin lymphoma (NHL) and its trends in the Asia Pacific.